http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6333327-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_535e2a57a80a9712c5371b3521fa1a3f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 2001-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af23a1889b489302f278208470d6c791
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b34617224bfa0733c6fef1ec505f322
publicationDate 2001-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6333327-B2
titleOfInvention Method for the treatment of Multiple Sclerosis
abstract Use of a compound of formula IwhereinR1 represents hydrogen or one or several, preferably 1 to 4, similar or different substituents in the positions 1-4 and/or 7-10, selected from halogen, preferably Br, lower alkyl/alkoxy group having not more than 4 carbon atoms, trifluoromethyl group, trichloromethyl group; and in one of the positions 7-10 R1 can be a hydroxyl group;X is a group -(CH2)n-R2, wherein R2 represents a nitrogen containing basic residue such as NH2, NHR4 or NR5R6, wherein R4, R5 and R6 independently are lower alkyl or cycloalkyl and n is an integer of from 1 to 4 and R3 represents hydrogen, lower alkyl/cycloalkyl group having not more than 4 carbon atoms, and the physiologically acceptable addition products of the compounds with acids and halogen adducts, preferably adducts with iodine, iodine monochloride or iodine monobromide, for preparing a drug for treatment of MS (multiple sclerosis).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2005254919-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7589093-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010009999-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005123741-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8084453-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005288296-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1976934-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6472395-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011086859-A9
priorityDate 2000-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4990510-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232356362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232356360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142418566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127880720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242947892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455055461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157626475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142418567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243038319
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18329727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69854170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129880907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448209824
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226600718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17819826

Total number of triples: 41.